Locations:
Dedicated multidisciplinary teams support 84 ultra-rare cancers
Targeting DNMT1 shows promise in chemotherapy- and immunotherapy-resistant SCLC
Immunological pressure driving genetic mutations
New review published in Cancers suggests a synergistic benefit
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Clinicians highlight the need to educate patients about warning signs
New research from Cleveland Clinic helps explain why these tumors are so refractory to treatment, and suggests new therapeutic avenues
A new analysis emphasizes the value of a multi-disciplinary approach.
Multicenter effort aims to standardize information about diagnosis and early management
Use of MRI adds to cost but remains cost-effective due to higher sensitivity
This approach led to local control for patients with brain metastases more than 2 cm in diameter
Advertisement
Advertisement
Search